Smith Medical Holdings Inc.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$23M
Investors
52
Min Invest
$10,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Smith Medical Holdings Inc. is a Florida corporation that first filed a Form D on November 10, 2022 and most recently amended it on April 30, 2026 in the Other Health Care industry group. The offering claims Rule 506(c) and covers equity and debt. Smith Medical Holdings Inc. reported $22,874,000 sold from 52 investors of a $24,874,000 total offering as of the Form D filed April 30, 2026. The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000. The Form D names Finalis Securities LLC (CRD 305908), associated with None as the recipient of sales compensation soliciting in IL. Sales commissions are reported as $0 and finders' fees as $50,000. Form D allows these to be estimates. The issuer's address of record is 800 Belle Terre Parkway, Suite 200-152, Palm Coast, FL 32164.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
1
latest Apr 30, 2026
Critical / warning
0 / 0
0 watch · 1 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
2
raising, lapsed
Latest event New filer · Apr 30, 2026
SEC.govInvestor
- 1 filing event with values and deltas, latest 2026-04-30, and alerts on the next one
- 2 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2026-04-30: 6 related persons added and 2 removed against the filing of 2023-01-18; 9 now listed. The names are in the Terminal feed.
Daniel Lee Barnett
Executive Officer, Director, Promoter · Flagler Beach, FL
Roy Lee Rose
Director, Promoter · Flagler Beach, FL
James Lee Mortinsen
Executive Officer, Director, Promoter · Flagler Beach, FL
Lisa Lee Cannon
Director · Flagler Beach, FL
Brendon Lee Lundberg
Promoter · Flagler Beach, FL
Mr. Lundberg was a promoter of the company and is no longer affiliated with the company.
Paul Lee Elliott
Executive Officer, Promoter · Flagler Beach, FL
Robert Lee Flintom
Executive Officer · Flagler Beach, FL
Vince Lee Calvanese
Executive Officer · Flagler Beach, FL
Craig Lee Loucks
Promoter · Flagler Beach, FL
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
Finalis Securities LLCCRD 305908 on BrokerCheck
Associated broker-dealer: None · New York, NY · Soliciting in IL
Questions About Smith Medical Holdings Inc.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Smith Medical Holdings Inc.?
Smith Medical Holdings Inc. is a Florida corporation that filed a Form D with the SEC on April 30, 2026 in the Other Health Care industry group. The filing claims Rule 506(c) for an offering of equity and debt.
Is Smith Medical Holdings Inc. legit?
AltStreet does not rate legitimacy; it reports the public record. Smith Medical Holdings Inc. filed a Form D with the SEC on April 30, 2026 claiming Rule 506(c). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $22,874,000 sold to 52 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Smith Medical Holdings Inc. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Smith Medical Holdings Inc. claimed Rule 506(c) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Smith Medical Holdings Inc. raised?
Smith Medical Holdings Inc. reported $22,874,000 sold from 52 investors of a $24,874,000 total offering as of the Form D filed April 30, 2026.
Who can invest in Smith Medical Holdings Inc.?
The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000.
What is the minimum investment in Smith Medical Holdings Inc.?
The Form D lists $10,000 as the minimum investment accepted from any outside investor as of April 30, 2026. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling Smith Medical Holdings Inc. and how are they paid?
The Form D names Finalis Securities LLC (CRD 305908), associated with None as the recipient of sales compensation soliciting in IL. Sales commissions are reported as $0 and finders' fees as $50,000. Form D allows these to be estimates.
Who is behind Smith Medical Holdings Inc.?
The Form D lists 9 related persons: Daniel Lee Barnett, executive officer, director, promoter; Roy Lee Rose, director, promoter; James Lee Mortinsen, executive officer, director, promoter; Lisa Lee Cannon, director; Brendon Lee Lundberg, promoter (Mr. Lundberg was a promoter of the company and is no longer affiliated with the company); Paul Lee Elliott, executive officer, promoter; Robert Lee Flintom, executive officer; Vince Lee Calvanese, executive officer, and 1 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Smith Medical Holdings Inc. located?
The issuer's address on its SEC filings is 800 Belle Terre Parkway, Suite 200-152, Palm Coast, FL 32164. Its phone number of record is 9498420380. It is organized under the laws of Florida.
How long is the Smith Medical Holdings Inc. offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 3 amendments are on record for this CIK.
What is Smith Medical Holdings Inc.'s revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
